Among these, the HLA‐B*07:02 was significantly associated with an increased risk of anaphylaxis, being present in 5 out of 33 patients but absent in all 41 tolerant controls (p = 0.015; OR = 7.15; 95% CI, 1.22–353.85). This evidence concerns the gene HLA-B and anaphylaxis.